BriaCell Therapeutics Corp

BCTX NASDAQ
BCTX
BriaCell Therapeutics Corp NASDAQ
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

BCTX financial statements: Cash flow

An in-depth look to BriaCell Therapeutics Corp operating, investing, and financing activities

BCTX free cash flow for Q3 21 is -5.58M. For 2020, BCTX free cash flow was -1.16M and operating cash flow was -1.16M.

TTM
Cash from operating activities
Funds from operations
Changes in working capital
Cash from investing activities
Purchase/sale of business, net
Purchase/sale of investments, net
Capital expenditures
Other investing cash flow items, total
Cash from financing activities
Issuance/retirement of stock, net
Issuance/retirement of debt, net
Total cash dividends paid
Other financing cash flow items, total
Free cash flow